|
| U.S. Brand
Names |
|
| Aphthasol™ |

|
|
| Generic
Available |
|
|
No |

|
|
| Pharmacological Index |
|
|
Anti-inflammatory, Locally Applied |

|
|
| Use |
|
|
Treatment of aphthous ulcers (ie, canker sores); has been investigated in
many allergic disorders |

|
|
| Pregnancy Risk
Factor |
|
|
B |

|
|
| Pregnancy/Breast-Feeding
Implications |
|
|
Due to lack of data, avoid use in pregnancy or lactation, if
possible |

|
|
| Contraindications |
|
|
Hypersensitivity to amlexanox or components |

|
|
| Warnings/Precautions |
|
|
Discontinue therapy if rash or contact mucositis
develops |

|
|
| Adverse
Reactions |
|
|
1% to 2%:
Dermatologic: Allergic contact dermatitis
Gastrointestinal: Oral irritation
<1%: Contact mucositis |

|
|
| Mechanism of
Action |
|
|
As a benzopyrano-bipyridine carboxylic acid derivative, amlexanox has
anti-inflammatory and antiallergic properties; it inhibits chemical mediatory
release of the slow-reacting substance of anaphylaxis (SRS-A) and may have
antagonistic effect son interleukin-3 |

|
|
| Pharmacodynamics/Kinetics |
|
|
Absorption: Systemic absorption with swallowing of topical application of
oral paste
Metabolism: Metabolized to hydroxylated and conjugated product
Half-life: 3.5 hours
Time to peak serum concentration: 2 hours
Elimination: 17% excreted unchanged |

|
|
| Usual Dosage |
|
|
Administer (0.5 cm - 1/4
") directly on ulcers 4 times/day following oral hygiene, after meals, and at
bedtime |

|
|
| Mental Health: Effects
on Mental Status |
|
|
None reported |

|
|
| Mental Health:
Effects on Psychiatric
Treatment |
|
|
None reported |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
Discontinue therapy if rash or contact mucositis
develops |

|
|
| Patient
Information |
|
|
Apply as soon as possible and continue 4 times/day (after meals and at
bedtime); wash hands after use; contact physician if no reduction in pain occurs
within 10 days |

|
|
| Dosage Forms |
|
|
Paste: 5% (5 g) |

|
|
| References |
|
|
Greer RO Jr, Lindenmuth JE, Juarez T, et al,
"A Double-Blind Study of Topically Applied 5% Amlexanox in the Treatment of Aphthous Ulcers,"
J Oral Maxillofac Surg, 1993, 51(3):243-8.
|

|
|
Copyright © 2007 Drugs Area
|